In addition to non-specific therapeutics, prostate cancer diagnosis using prostate specific antigen (PSA) blood levels is no longer recommended for use by the United States Preventive Services Task Force (USPSTF) [9-13]. This evidence concerns the gene KLK3 and prostate carcinoma.